Article Details
Retrieved on: 2021-03-30 11:11:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The US pharma is mounting a challenge to Roche, which markets an antibody therapy, Gazyvaro (obinutuzumab) in advanced CLL. Like Gazyvaro ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here